Loading...
Stereotactic prostate adaptive radiotherapy utilising kilovoltage intrafraction monitoring: the TROG 15.01 SPARK trial
BACKGROUND: This paper describes the multi-institutional prospective phase II clinical trial, SPARK: Stereotactic Prostate Adaptive Radiotherapy utilizing Kilovoltage Intrafraction Monitoring (KIM). KIM is a real-time image guided radiotherapy technology being developed and clinically pioneered for...
Saved in:
| Published in: | BMC Cancer |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2017
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5341369/ https://ncbi.nlm.nih.gov/pubmed/28270121 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3164-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|